These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2419034)

  • 1. Natural killer cells.
    Kay NE
    Crit Rev Clin Lab Sci; 1986; 22(4):343-59. PubMed ID: 2419034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P; Zaytoun AM; Lee JH; Fauci AS
    J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
    [No Abstract]   [Full Text] [Related]  

  • 3. Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.
    Virelizier JL; Lipinski M; Tursz T; Griscelli C
    Lancet; 1979 Sep; 2(8144):696-7. PubMed ID: 90787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of natural killer cell activity].
    Abo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
    [No Abstract]   [Full Text] [Related]  

  • 5. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
    Haliotis T; Roder J; Klein M; Ortaldo J; Fauci AS; Herberman RB
    J Exp Med; 1980 May; 151(5):1039-48. PubMed ID: 6154765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of lymphocyte populations].
    Flad HD
    Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
    [No Abstract]   [Full Text] [Related]  

  • 8. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
    Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
    J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon and natural killer cells].
    Saksela E
    Duodecim; 1980; 96(16):1061-4. PubMed ID: 6164530
    [No Abstract]   [Full Text] [Related]  

  • 10. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
    Brahmi Z
    Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
    Lotzová E; Savary CA; Gutterman JU; Hersh EM
    Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
    [No Abstract]   [Full Text] [Related]  

  • 13. A new immunodeficiency disorder in humans involving NK cells.
    Roder JC; Haliotis T; Klein M; Korec S; Jett JR; Ortaldo J; Heberman RB; Katz P; Fauci AS
    Nature; 1980 Apr; 284(5756):553-5. PubMed ID: 6445041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity in a patient with Chédiak-Higashi syndrome submitted to bone marrow transplantation.
    Diamond HR; Souza MH; Silva ML; Tabak DG; Ferman S; M-Silva VM; de La Rocque L; Rumjanek VM
    Pediatr Hematol Oncol; 1995; 12(4):399-402. PubMed ID: 7577393
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies of natural killer cell function in Chediak-Higashi patients.
    Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
    Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse.
    Ito M; Sato A; Tanabe F; Ishida E; Takami Y; Shigeta S
    Biochem Biophys Res Commun; 1989 Apr; 160(2):433-40. PubMed ID: 2541700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
    Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
    Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells in resistance to virus-infected cells.
    Rager-Zisman B; Bloom BR
    Springer Semin Immunopathol; 1982; 4(4):397-414. PubMed ID: 6183763
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
    Abo T; Roder JC; Abo W; Cooper MD; Balch CM
    J Clin Invest; 1982 Jul; 70(1):193-7. PubMed ID: 7085883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activity in untreated systemic lupus erythematosus.
    Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
    Ann Rheum Dis; 1982 Aug; 41(4):417-20. PubMed ID: 7114924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.